SCHEMBL7280704

SCHEMBL7280704

CCCNc1ncc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN2A Q99250 5/20 0.49
KCNK2 O95069 1/20 0.49
FGFR1 P11362 5/20 0.43
SCN10A Q9Y5Y9 6/20 0.43
SCN9A Q15858 3/20 0.43
SCN3A Q9NY46 3/20 0.43
SCN1A P35498 1/20 0.43
KCNH2 Q12809 1/20 0.43
SCN5A Q14524 1/20 0.43
NR1I2 O75469 1/20 0.36
AHR P35869 1/20 0.36
EGFR P00533 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HSP90AA1 P07900 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6049498 0.90 SCN2A (0.51) SCN2AKCNK2FGFR1SCN10ASCN9A
SCHEMBL6049564 0.82 SCN2A (0.54) SCN2AKCNK2FGFR1SCN10ASCN9A
SCHEMBL168973 0.74 SCN2A (0.57) SCN2AKCNK2FGFR1SCN10ASCN9A
SCHEMBL30413525 0.74 SCN2A (0.57) SCN2AKCNK2FGFR1SCN10ASCN9A
SCHEMBL7278590 0.74 SCN2A (0.51) SCN2AKCNK2FGFR1SCN10ASCN9A
SCHEMBL15914195 0.72 SCN2A (0.49) SCN2AKCNK2FGFR1SCN10ASCN9A
SCHEMBL6049521 0.71 SCN2A (0.54) SCN2AKCNK2FGFR1SCN10ASCN9A
SCHEMBL132945 0.69 SCN2A (0.77) SCN2AKCNK2SCN9ALMNAMAPT
SCHEMBL21657680 0.68 DHFR (0.39) MERTKADORA1
SCHEMBL7272688 0.68 SCN2A (0.77) SCN2AKCNK2SCN10ASCN9ASCN3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0679645-A1 Pharmacologically active CNS pyridmidin compounds THE WELLCOME FOUNDATION LIMITED (GB) 1995-11-02 EP disclosed
EP-0459819-A2 Pharmacologically active CNS compound THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-04 EP disclosed